The McDevitt lab is focused on the engineering of innovative technologies to translate the morphogenic potential of stem cells as models of development and disease, as well to develop cellular and molecular therapies aimed to treat degenerative diseases and traumatic injuries. Learn more about the research.
Since stem cells are promising for a number of applications, the emphasis of the McDevitt Lab is on the development of technology platforms to advance therapies that span multiple diseases.
Our technologies are applicable to a wide variety of diseases, including cardiovascular, orthopedic and neurological disorders. Specific diseases that we can apply our research to include treatments for diabetes, chronic wounds, aging, arthritis and other autoimmune disorders. The McDevitt lab's work also has other applications, including wound healing, irritable bowel syndrome, epilepsy and bone regeneration to name just a few.
Click here for a complete list of research and disease applications.
Engineering Stem Cell TechnologiesCreating tissue models to study new approaches to treat diseases that afflict the cardiovascular, neurological, immunological, and musculoskeletal systems
Moved WestWith the help of the CIRM Research Leadership Award the lab moved in 2015 to the Gladstone Institutes
A Magnet for BiotechnologyMission Bay, where the first research building opened in 2003, has bloomed into a vibrant and vital campus and magnet to the booming San Francisco Bay Area biotechnology industry
The Gladstone InstitutesNew home of the McDevitt Laboratory
New BiotherapeuticsInsights into stem cell and developmental biology, facilitate new regenerative therapies, and create novel microtissue diagnostic and pharmaceutical platforms
